Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 7, 2025 • 3:00 AM ET

Date/Time Source News Release
05/12/2025 04:05 PM EDT GlobeNewswire Bolt Biotherapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
05/08/2025 08:00 AM EDT GlobeNewswire Bolt Biotherapeutics to Host KOL Conference Call and Webcast to Discuss BDC-3042 Phase 1 Results and Corporate Updates
04/30/2025 04:05 PM EDT GlobeNewswire Bolt Biotherapeutics Presents Preclinical Results for Next-Generation Boltbody(TM) ISACs targeting CEA and PD-L1 at AACR Annual Meeting 2025
04/25/2025 01:00 PM EDT GlobeNewswire Bolt Biotherapeutics Presents Results from the Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025
03/25/2025 04:30 PM EDT GlobeNewswire Bolt Biotherapeutics to Present Data from Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025
03/24/2025 04:20 PM EDT GlobeNewswire Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update
02/25/2025 04:05 PM EST GlobeNewswire Bolt Biotherapeutics to Participate in Upcoming March Conferences
02/11/2025 04:05 PM EST GlobeNewswire Bolt Biotherapeutics, Inc. Provides Update on Global Cancer Immunotherapy Co-Development with Toray Industries, Inc.
11/12/2024 04:05 PM EST GlobeNewswire Bolt Biotherapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update
11/07/2024 10:00 AM EST GlobeNewswire Bolt Biotherapeutics Presents Updated Preclinical Data for BDC-4182 and Key Learnings from Phase 1 Dose-Escalation Trial of BDC-1001 at SITC 39th Annual Meeting
Page

Additional News

As of June 7, 2025 • 3:00 AM ET

Date/Time Source News Release
05/13/2025 08:57 AM EDT SeekingAlpha Bolt Biotherapeutics GAAP EPS of -$0.29, revenue of $1.2M
05/13/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Tuesday, May 13th, 2025
05/13/2025 05:30 AM EDT US Earnings Reports Expected earnings - Bolt Biotherapeutics Inc.
05/12/2025 05:25 PM EDT Zacks Bolt Biotherapeutics, Inc. (BOLT) Reports Q1 Loss, Tops Revenue Estimates
05/12/2025 05:10 PM EDT Zacks Arcturus Therapeutics (ARCT) Reports Q1 Loss, Tops Revenue Estimates
05/08/2025 05:50 PM EDT Zacks Prothena (PRTA) Reports Q1 Loss, Misses Revenue Estimates
03/24/2025 04:29 PM EDT SeekingAlpha Bolt Biotherapeutics GAAP EPS of -$0.42 misses by $0.04
03/20/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Thursday, March 20th, 2025
03/20/2025 05:30 AM EDT US Earnings Reports Expected earnings - Bolt Biotherapeutics Inc.
02/27/2025 05:15 PM EST Zacks Cytokinetics (CYTK) Reports Q4 Loss, Misses Revenue Estimates
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.